<p>根據 MarketBeat Ratings 的報告，Select Medical Holdings Corporation（紐約證券交易所代碼：SEM - 獲取免費報告）的股票被目前覆蓋該公司的五家經紀公司賦予了 “適度買入” 的共識評級。一位股票研究分析師給予該股票持有評級，四位分析師則給予買入評級。在過去一年中，對該股票發佈評級的分析師的平均 12 個月目標價為 26.00 美元。</p>
<p>獲取 <strong>Select Medical</strong> 警報：</p>
<p>最近，一些股票研究分析師對 SEM 股票進行了評估。加拿大皇家銀行在 5 月 7 日的研究報告中將 Select Medical 的目標價從 23.00 美元下調至 19.00 美元，並對該公司設定了 “跑贏大盤” 的評級。瑞穗證券在 4 月 16 日的研究報告中開始覆蓋 Select Medical，給予 “跑贏大盤” 評級和 25.00 美元的目標價。</p>
<p><strong>獲取我們對 Select Medical 的最新股票分析</strong></p>
<h2>Select Medical 的內部活動</h2>
<p>在其他 Select Medical 的新聞中，首席執行官 David S. Chernow 在 4 月 28 日星期一出售了 225,000 股公司的股票，交易平均價格為 18.00 美元，總交易額為 4,050,000.00 美元。交易後，首席執行官現在持有 714,516 股公司股票，價值約為 12,861,288 美元。這代表其持股比例下降了 23.95%。該交易已在證券交易委員會的法律文件中披露，相關信息可通過 SEC 網站獲取。此外，董事 Parvinderjit S. Khanuja 在 5 月 5 日星期一購買了 21,000 股 Select Medical 的股票，交易平均價格為每股 15.02 美元，總交易額為 315,420.00 美元。收購後，該董事現在直接持有 65,089 股公司股票，價值約為 977,636.78 美元。這筆交易代表其持股比例增加了 47.63%。該購買的披露信息可以在這裏找到。公司內部人士持有 11.60% 的股票。</p>
<h2>Select Medical 的機構交易</h2>
<p>一些對沖基金最近對該股票的持倉進行了調整。Voya Investment Management LLC 在第一季度將其在 Select Medical 的持倉增加了 48.7%。Voya Investment Management LLC 現在持有 1,507,349 股該健康服務提供商的股票，價值 25,173,000 美元，此前在上個季度購買了 493,983 股。Strs Ohio 在第一季度購買了 Select Medical 的新股份，價值約為 773,000 美元。Intech Investment Management LLC 在第一季度將其在 Select Medical 的持倉增加了 21.2%。Intech Investment Management LLC 現在持有 176,721 股該健康服務提供商的股票，價值 2,951,000 美元，此前在上個季度購買了 30,892 股。Jane Street Group LLC 在第一季度購買了 Select Medical 的新股份，價值約為 4,635,000 美元。最後，瑞銀資產管理美洲有限公司的一個獨特業務單位在第一季度將其在 Select Medical 的持倉增加了 3.3%。瑞銀資產管理美洲有限公司的這個獨特業務單位現在持有 323,968 股該健康服務提供商的股票，價值 5,410,000 美元，此前在上個季度購買了 10,329 股。89.48% 的股票由機構投資者持有。</p>
<h2>Select Medical 股票上漲 1.7%</h2>
<p>NYSE:SEM 的股票在週一以 15.27 美元開盤。Select Medical 的 52 周低點為 14.03 美元，52 周高點為 40.98 美元。該公司的 50 日移動平均線為 15.39 美元，200 日移動平均線為 17.19 美元。該公司的市值為 19.6 億美元，市盈率為 11.39，市盈率增長比率為 0.81，貝塔係數為 1.34。該公司的債務與股本比率為 0.87，速動比率為 1.16，流動比率為 1.16。</p>
<p>Select Medical（NYSE:SEM - 獲取免費報告）最近於 5 月 1 日星期四發佈了季度財報。該健康服務提供商報告季度每股收益為 0.44 美元，低於市場共識預期的 0.45 美元（差額為 0.01 美元）。Select Medical 的股本回報率為 11.04%，淨利潤率為 2.81%。該公司在本季度的收入為 13.5 億美元，而分析師預期為 14 億美元。在去年同期，該公司每股收益為 0.75 美元。該公司的季度收入同比下降了 24.4%。整體而言，研究分析師預計 Select Medical 在本財年將發佈 1.17 美元的每股收益。</p>
<p>Select Medical 宣佈其董事會已於 5 月 1 日星期四啓動了一項股票回購計劃，允許公司回購 10 億美元的流通股。這項回購授權允許該健康服務提供商通過公開市場購買最多 42.6% 的股票。股票回購計劃通常表明公司的董事會認為其股票被低估。</p>
<h2>Select Medical 宣佈分紅</h2>
<p>該公司最近還宣佈了一項季度分紅，於 5 月 29 日星期四支付。5 月 15 日的登記投資者獲得每股 0.0625 美元的分紅。該分紅的除息日為 5 月 15 日。這代表年化分紅為 0.25 美元，收益率為 1.64%。Select Medical 的分紅支付比率目前為 18.66%。</p>
<h2>關於 Select Medical</h2>
<p>（獲取免費報告）</p>
<p>Select Medical Holdings Corporation 通過其子公司在美國運營重症恢復醫院、康復醫院、門診康復診所和職業健康中心。它分為四個部門：重症恢復醫院、康復醫院、門診康復和 Concentra。</p>
<h2>另見</h2>
<ul>
<li>我們更看好的五隻股票，而非 Select Medical</li>
<li>股票分析師評級和加拿大分析師評級</li>
<li>AutoNation：增長引擎使其成為被低估的股票</li>
<li>什麼是分紅成長股？簡介</li>
<li>Snowflake 創下 52 周新高——期權交易者押注進一步上漲</li>
<li>消費者價格指數測量什麼？</li>
<li>3 只值得關注的生物科技股票：Iovance、Neurocrine 和 Viking</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNFTQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNFTQ"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。請將任何問題或意見發送至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資 $1,000 在 Select Medical 嗎？</h2>
<p>在考慮 Select Medical 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買……而 Select Medical 並不在名單上。</p>
<p>雖然 Select Medical 目前在分析師中有中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

Select醫藥控股

<p>Select Medical Holdings Corporation（紐約證券交易所代碼：SEM）獲得了五家券商的 “適度買入” 共識評級。分析師設定的 12 個月平均目標價為 26.00 美元。最近的內部交易包括首席執行官 David S. Chernow 出售 225,000 股，以及董事 Parvinderjit S. Khanuja 購買 21,000 股。該股票開盤價為 15.27 美元，52 周範圍為 14.03 美元至 40.98 美元。Select Medical 報告的季度每股收益為 0.44 美元，低於預期，營收為 13.5 億美元，同比下降 24.4%</p>

<p>Shares of Select Medical Holdings Corporation (NYSE:SEM - Get Free Report) have been assigned a consensus rating of &#34;Moderate Buy&#34; from the five brokerages that are presently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $26.00.</p>
<div class="lb-trans"><p>根據 MarketBeat Ratings 的報告，Select Medical Holdings Corporation（紐約證券交易所代碼：SEM - 獲取免費報告）的股票被目前覆蓋該公司的五家經紀公司賦予了 “適度買入” 的共識評級。一位股票研究分析師給予該股票持有評級，四位分析師則給予買入評級。在過去一年中，對該股票發佈評級的分析師的平均 12 個月目標價為 26.00 美元。</p>
</div><p>Get <strong>Select Medical</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Select Medical</strong> 警報：</p>
</div><p>A number of equities research analysts have recently weighed in on SEM shares. Royal Bank Of Canada lowered their target price on Select Medical from $23.00 to $19.00 and set an &#34;outperform&#34; rating for the company in a research note on Wednesday, May 7th. Mizuho started coverage on Select Medical in a research note on Wednesday, April 16th. They issued an &#34;outperform&#34; rating and a $25.00 target price for the company.</p>
<div class="lb-trans"><p>最近，一些股票研究分析師對 SEM 股票進行了評估。加拿大皇家銀行在 5 月 7 日的研究報告中將 Select Medical 的目標價從 23.00 美元下調至 19.00 美元，並對該公司設定了 “跑贏大盤” 的評級。瑞穗證券在 4 月 16 日的研究報告中開始覆蓋 Select Medical，給予 “跑贏大盤” 評級和 25.00 美元的目標價。</p>
</div><p><strong>Get Our Latest Stock Analysis on Select Medical</strong></p>
<div class="lb-trans"><p><strong>獲取我們對 Select Medical 的最新股票分析</strong></p>
</div><h2>Insider Activity at Select Medical</h2>
<div class="lb-trans"><h2>Select Medical 的內部活動</h2>
</div><p>In other Select Medical news, CEO David S. Chernow sold 225,000 shares of the company's stock in a transaction that occurred on Monday, April 28th. The stock was sold at an average price of $18.00, for a total transaction of $4,050,000.00. Following the transaction, the chief executive officer now owns 714,516 shares in the company, valued at approximately $12,861,288. This represents a 23.95% decrease in their position. The transaction was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is accessible through the SEC website. Also, Director Parvinderjit S. Khanuja bought 21,000 shares of Select Medical stock in a transaction on Monday, May 5th. The shares were purchased at an average price of $15.02 per share, for a total transaction of $315,420.00. Following the acquisition, the director now directly owns 65,089 shares in the company, valued at approximately $977,636.78. This trade represents a 47.63% increase in their position. The disclosure for this purchase can be found here. 11.60% of the stock is owned by company insiders.</p>
<div class="lb-trans"><p>在其他 Select Medical 的新聞中，首席執行官 David S. Chernow 在 4 月 28 日星期一出售了 225,000 股公司的股票，交易平均價格為 18.00 美元，總交易額為 4,050,000.00 美元。交易後，首席執行官現在持有 714,516 股公司股票，價值約為 12,861,288 美元。這代表其持股比例下降了 23.95%。該交易已在證券交易委員會的法律文件中披露，相關信息可通過 SEC 網站獲取。此外，董事 Parvinderjit S. Khanuja 在 5 月 5 日星期一購買了 21,000 股 Select Medical 的股票，交易平均價格為每股 15.02 美元，總交易額為 315,420.00 美元。收購後，該董事現在直接持有 65,089 股公司股票，價值約為 977,636.78 美元。這筆交易代表其持股比例增加了 47.63%。該購買的披露信息可以在這裏找到。公司內部人士持有 11.60% 的股票。</p>
</div><h2>Institutional Trading of Select Medical</h2>
<div class="lb-trans"><h2>Select Medical 的機構交易</h2>
</div><p>A number of hedge funds have recently made changes to their positions in the stock. Voya Investment Management LLC boosted its position in shares of Select Medical by 48.7% in the 1st quarter. Voya Investment Management LLC now owns 1,507,349 shares of the health services provider's stock worth $25,173,000 after purchasing an additional 493,983 shares in the last quarter. Strs Ohio bought a new stake in shares of Select Medical in the 1st quarter worth approximately $773,000. Intech Investment Management LLC boosted its position in shares of Select Medical by 21.2% in the 1st quarter. Intech Investment Management LLC now owns 176,721 shares of the health services provider's stock worth $2,951,000 after purchasing an additional 30,892 shares in the last quarter. Jane Street Group LLC bought a new stake in shares of Select Medical in the 1st quarter worth approximately $4,635,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in shares of Select Medical by 3.3% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 323,968 shares of the health services provider's stock worth $5,410,000 after purchasing an additional 10,329 shares in the last quarter. 89.48% of the stock is owned by institutional investors.</p>
<div class="lb-trans"><p>一些對沖基金最近對該股票的持倉進行了調整。Voya Investment Management LLC 在第一季度將其在 Select Medical 的持倉增加了 48.7%。Voya Investment Management LLC 現在持有 1,507,349 股該健康服務提供商的股票，價值 25,173,000 美元，此前在上個季度購買了 493,983 股。Strs Ohio 在第一季度購買了 Select Medical 的新股份，價值約為 773,000 美元。Intech Investment Management LLC 在第一季度將其在 Select Medical 的持倉增加了 21.2%。Intech Investment Management LLC 現在持有 176,721 股該健康服務提供商的股票，價值 2,951,000 美元，此前在上個季度購買了 30,892 股。Jane Street Group LLC 在第一季度購買了 Select Medical 的新股份，價值約為 4,635,000 美元。最後，瑞銀資產管理美洲有限公司的一個獨特業務單位在第一季度將其在 Select Medical 的持倉增加了 3.3%。瑞銀資產管理美洲有限公司的這個獨特業務單位現在持有 323,968 股該健康服務提供商的股票，價值 5,410,000 美元，此前在上個季度購買了 10,329 股。89.48% 的股票由機構投資者持有。</p>
</div><h2>Select Medical Stock Up 1.7%</h2>
<div class="lb-trans"><h2>Select Medical 股票上漲 1.7%</h2>
</div><p>Shares of NYSE:SEM opened at $15.27 on Monday. Select Medical has a 52-week low of $14.03 and a 52-week high of $40.98. The firm has a fifty day moving average of $15.39 and a 200 day moving average of $17.19. The firm has a market capitalization of $1.96 billion, a PE ratio of 11.39, a price-to-earnings-growth ratio of 0.81 and a beta of 1.34. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.16 and a current ratio of 1.16.</p>
<div class="lb-trans"><p>NYSE:SEM 的股票在週一以 15.27 美元開盤。Select Medical 的 52 周低點為 14.03 美元，52 周高點為 40.98 美元。該公司的 50 日移動平均線為 15.39 美元，200 日移動平均線為 17.19 美元。該公司的市值為 19.6 億美元，市盈率為 11.39，市盈率增長比率為 0.81，貝塔係數為 1.34。該公司的債務與股本比率為 0.87，速動比率為 1.16，流動比率為 1.16。</p>
</div><p>Select Medical (NYSE:SEM - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The health services provider reported $0.44 EPS for the quarter, missing the consensus estimate of $0.45 by ($0.01). Select Medical had a return on equity of 11.04% and a net margin of 2.81%. The company had revenue of $1.35 billion during the quarter, compared to analysts' expectations of $1.40 billion. During the same quarter in the prior year, the firm posted $0.75 EPS. The firm's quarterly revenue was down 24.4% on a year-over-year basis. As a group, research analysts anticipate that Select Medical will post 1.17 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Select Medical（NYSE:SEM - 獲取免費報告）最近於 5 月 1 日星期四發佈了季度財報。該健康服務提供商報告季度每股收益為 0.44 美元，低於市場共識預期的 0.45 美元（差額為 0.01 美元）。Select Medical 的股本回報率為 11.04%，淨利潤率為 2.81%。該公司在本季度的收入為 13.5 億美元，而分析師預期為 14 億美元。在去年同期，該公司每股收益為 0.75 美元。該公司的季度收入同比下降了 24.4%。整體而言，研究分析師預計 Select Medical 在本財年將發佈 1.17 美元的每股收益。</p>
</div><p>Select Medical declared that its Board of Directors has initiated a share repurchase plan on Thursday, May 1st that allows the company to buyback $1.00 billion in outstanding shares. This buyback authorization allows the health services provider to reacquire up to 42.6% of its stock through open market purchases. Stock buyback plans are often an indication that the company's board of directors believes its shares are undervalued.</p>
<div class="lb-trans"><p>Select Medical 宣佈其董事會已於 5 月 1 日星期四啓動了一項股票回購計劃，允許公司回購 10 億美元的流通股。這項回購授權允許該健康服務提供商通過公開市場購買最多 42.6% 的股票。股票回購計劃通常表明公司的董事會認為其股票被低估。</p>
</div><h2>Select Medical Announces Dividend</h2>
<div class="lb-trans"><h2>Select Medical 宣佈分紅</h2>
</div><p>The firm also recently declared a quarterly dividend, which was paid on Thursday, May 29th. Investors of record on Thursday, May 15th were issued a dividend of $0.0625 per share. The ex-dividend date of this dividend was Thursday, May 15th. This represents a $0.25 dividend on an annualized basis and a yield of 1.64%. Select Medical's dividend payout ratio is presently 18.66%.</p>
<div class="lb-trans"><p>該公司最近還宣佈了一項季度分紅，於 5 月 29 日星期四支付。5 月 15 日的登記投資者獲得每股 0.0625 美元的分紅。該分紅的除息日為 5 月 15 日。這代表年化分紅為 0.25 美元，收益率為 1.64%。Select Medical 的分紅支付比率目前為 18.66%。</p>
</div><h2>About Select Medical</h2>
<div class="lb-trans"><h2>關於 Select Medical</h2>
</div><p>(Get Free Report</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.</p>
<div class="lb-trans"><p>Select Medical Holdings Corporation 通過其子公司在美國運營重症恢復醫院、康復醫院、門診康復診所和職業健康中心。它分為四個部門：重症恢復醫院、康復醫院、門診康復和 Concentra。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另見</h2>
</div><ul>
<li>Five stocks we like better than Select Medical</li>
<li>Stock Analyst Ratings and Canadian Analyst Ratings</li>
<li>AutoNation: Growth Engines Make It an Undervalued Stock</li>
<li>What Are Dividend Achievers? An Introduction</li>
<li>Snowflake Hits 52-Week High—Options Traders Bet on Further Rally</li>
<li>What does consumer price index measure?</li>
<li>3 Biotech Stocks to Watch: Iovance, Neurocrine &amp; Viking</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票，而非 Select Medical</li>
<li>股票分析師評級和加拿大分析師評級</li>
<li>AutoNation：增長引擎使其成為被低估的股票</li>
<li>什麼是分紅成長股？簡介</li>
<li>Snowflake 創下 52 周新高——期權交易者押注進一步上漲</li>
<li>消費者價格指數測量什麼？</li>
<li>3 只值得關注的生物科技股票：Iovance、Neurocrine 和 Viking</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNFTQ" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NYSE&amp;Symbol=SEM"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。請將任何問題或意見發送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Select Medical Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 $1,000 在 Select Medical 嗎？</h2>
</div><p>Before you consider Select Medical, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Select Medical 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Select Medical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買……而 Select Medical 並不在名單上。</p>
</div><p>While Select Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Select Medical 目前在分析師中有中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Select Medical Holdings Corporation（紐約證券交易所代碼：SEM）被分析師一致推薦為 “適度買入”